Have Researchers Just Found Another Cause of Parkinson’s Disease?

Translate to Spanish or other 102 languages!

New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes
New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers from the University of Copenhagen, in Denmark, have made an important breakthrough in our understanding of Parkinson’s disease.
  • Their discovery centres around the damage of mitochondrial DNA in brain cells and its potential as an early biomarker for the disease.
  • As this condition affects over 10 million individuals worldwide, these findings hold significant promise for the future of diagnostics and treatments.
  • With the implications of these damaged DNA pieces likened to an unchecked forest blaze, the research provides hope and a fresh direction in understanding and treating this condition.

Parkinson’s disease is a neurological condition that impacts movement. Initial symptoms involve shaking, diminished sense of smell and difficulties with coordination.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/have-researchers-just-found-another-cause-of-parkinsons-disease

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.
- Advertisement -